Catalyst Wire Dossier Catalyst Wire Dossier

TN-001 Topical Eyedrops

TN-001 · TheiaNova Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TN-001 Topical Eyedrops, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of TN-001 Topical Eyedrops for Keratoconus [Phase 1, Phase 2]

See pricing